AI

AI Can Draft Contracts—But Can You Trust Them?

Rachelle Soderstrom

Rochelle C. Mulondo

AI Collaborations – From Strategic License to Strategic Acquisition

Joshua Hofheimer

Children’s Privacy in 2026: From Australia’s Under-16 Social Media Ban to a Shift Beyond Notice-and-Consent in the United States

Michael C. Hochman

Colleen Theresa Brown

Sheri Porath Rockwell

Complying with New EU AI Act Transparency Obligations

Francesca Blythe

Eleanor Dodding

Courts Set Clear Standards for How Lawyers Use AI in Litigation

Gregory Lantier

Gilbert Smolenski

Current AI Usage Rules in the Most Popular Patent Infringement Case Venues

Gregory Lantier

Gilbert Smolenski

Cyber Strategy at the AI Frontier: President Trump Releases Executive Order to Promote Advanced Artificial Intelligence Innovation and Security

David C. Lashway

Jennifer B. Seale

Michael C. Hochman

Earnouts, AI, and Equitable Remedies: Delaware Court Reinstates CEO and Extends Payout Clock

Sharon Flanagan

Sally Wagner-Partin

European Data Protection Board Publishes Draft Guidelines on Anonymisation

Francesca Blythe

Matthias Bruynseraede

FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight Paradigm

Jaclyn G. Fonteyne

Generative AI and Privilege: Practical Lessons from Two Early Decisions and What Comes Next

David A. Gordon

Matt S. Jackson

William J. Lawrence

Kseniya K. Belysheva

Generative AI in Discovery: Protective Orders as an Emerging Point of Dispute

David A. Gordon

Matt S. Jackson

Stephen Beemsterboer

Generative AI Meets Copyright Scrutiny

Lauren M. De Lilly

Nima H. Mohebbi

Rollin A. Ransom

Kristina Martinez

Getting Your House in Order: Corporate Housekeeping in Preparation for a Major Transaction

If Your AI Vendor Goes Bankrupt: Keeping Licensed IP Access

Andrew M. Klauber

Andrew Townsell

Anthony R. Grossi

If Your AI Vendor Goes Bankrupt: Tackling Privacy and ‘Utility’

Andrew M. Klauber

Andrew Townsell

Anthony R. Grossi

Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled tools

Dr. Chris Boyle

Zina Chatzidimitriadou

Legal Implications in AI Development and Deployment: Training Data and Grounding Data

Stephen M. Fronk

Legal Issues Arising From the Use of Artificial Intelligence in Drug Development

Adriana V. Tibbitts

Alison M. Lehner

Taming the AI Wild West: Do’s and Don’ts for Responsible GenAI Use

Rachelle Soderstrom

Sheri Porath Rockwell

The AI Patent Litigation War Hasn’t Started—But It’s Coming Fast

There’s a New Sheriff in Town — Texas as Privacy Regulator

The Trump Administration’s 2025 AI Action Plan – Winning the Race: America’s AI Action Plan – and Related Executive Orders

Colleen Theresa Brown

Michael E. Borden

Sharon Flanagan

Michael C. Hochman

The UK’s First Copyright vs. AI Decision: Key Takeaways on a Win for the AI Industry

Elisabetta Righini

UK Looks To Modernize Medicines And Medical Device Regulation In The Era Of AI

Dr. Chris Boyle

Zina Chatzidimitriadou

Unpacking the December 11, 2025 Executive Order: Ensuring a National Policy Framework for Artificial Intelligence

Colleen Theresa Brown

Michael C. Hochman

Kwaku A. Akowuah

Michael E. Borden

Christopher T. Shenk

What Do the European Data Protection Board’s Web Scraping Guidelines Mean for AI Training Datasets?

Francesca Blythe

Eleanor Dodding

When AI Changes the Deal: Rethinking Risk, Milestones, and Timing in Life Sciences M&A

Sally Wagner-Partin

Sharon Flanagan

When “The Devil Made Me Do It” Is Not a Defense: Lessons in AI Governance and Organizational Oversight from an SDNY Decision

David A. Gordon

Matt S. Jackson

Kseniya K. Belysheva